RYTM
Rhythm Pharmaceuticals Inc Earnings
$90.42
Earnings Summary
Revenue | $57.25Mn |
Net Profits | $-47.51Mn |
Net Profit Margins | -82.97% |
Rhythm Pharmaceuticals Inc’s revenue jumped 36.87% since last year same period to $57.25Mn in the Q4 2025. On a quarterly growth basis, Rhythm Pharmaceuticals Inc has generated 11.61% jump in its revenue since last 3-months.
Rhythm Pharmaceuticals Inc’s net profit fell -9.73% since last year same period to $-47.51Mn in the Q4 2025. On a quarterly growth basis, Rhythm Pharmaceuticals Inc has generated 10.21% jump in its net profits since last 3-months.
Rhythm Pharmaceuticals Inc’s net profit margin jumped 19.83% since last year same period to -82.97% in the Q4 2025. On a quarterly growth basis, Rhythm Pharmaceuticals Inc has generated 19.55% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.82 |
EPS Estimate Current Year | -0.82 |
Rhythm Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at -0.82 - a 0.07% jump from last quarter’s estimates.
Rhythm Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at -0.82.
Key Ratios
Earning Per Share (EPS) | 0 |
Rhythm Pharmaceuticals Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2026. This indicates that the Rhythm Pharmaceuticals Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-05-12 | -0.82 | 0 | 100% |
